| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |